chr1-26892705-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022078.3(GPATCH3):c.1198G>A(p.Glu400Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000226 in 1,614,190 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022078.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPATCH3 | NM_022078.3 | c.1198G>A | p.Glu400Lys | missense_variant | 5/7 | ENST00000361720.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPATCH3 | ENST00000361720.10 | c.1198G>A | p.Glu400Lys | missense_variant | 5/7 | 1 | NM_022078.3 | P1 | |
GPATCH3 | ENST00000450844.1 | c.52G>A | p.Glu18Lys | missense_variant | 1/3 | 2 | |||
GPATCH3 | ENST00000445019.5 | c.148G>A | p.Glu50Lys | missense_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000163 AC: 41AN: 251430Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135882
GnomAD4 exome AF: 0.000229 AC: 335AN: 1461886Hom.: 1 Cov.: 31 AF XY: 0.000217 AC XY: 158AN XY: 727248
GnomAD4 genome AF: 0.000190 AC: 29AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.1198G>A (p.E400K) alteration is located in exon 5 (coding exon 5) of the GPATCH3 gene. This alteration results from a G to A substitution at nucleotide position 1198, causing the glutamic acid (E) at amino acid position 400 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at